Skip to content

Impact of Low-Level Laser Therapy on Hair Regrowth Post PRP Treatment

Impact of Low-Level Laser Therapy on Hair Regrowth Post PRP Treatment

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07048626
Enrollment
22
Registered
2025-07-02
Start date
2025-03-17
Completion date
2026-02-28
Last updated
2025-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Baldness

Brief summary

Low-level laser stimulates cells in the hair follicles, which promotes hair growth. The patient's own blood platelets are used in platelet-rich plasma treatment to encourage hair growth. Combining low-level laser treatment with platelet-rich plasma will promote hair growth in patients.

Detailed description

To determine the impact of low-level laser therapy on hair regrowth following prp treatment. This will be case control study conducted on 22 participants with androgenetic alopecia (AGA).

Interventions

COMBINATION_PRODUCTPRP treatment

PRP treatment involves drawing a blood sample, processing it to concentrate platelets, and then injecting that concentrated plasma back into the body, typically at the site of an injury or area needing regeneration. The procedure aims to utilize the growth factors within the platelets to accelerate healing and tissue repair.

COMBINATION_PRODUCTlow level laser therapy post prp treatment

will receive low-level laser therapy post prp treatment upto 12 weeks .Low-level laser therapy (LLLT) is a non-invasive treatment for hair loss that uses low-intensity laser light to stimulate hair follicles and improve blood circulation. It's often used on its own or combined with other therapies like PRP.

Sponsors

Superior University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults between 18-35 years diagnosed with androgenic alopecia or other non-scarring hair loss conditions. * Having the Norwood-Hamilton scale placed in stages I-V for men Ludwig scale in stages I-III for women .

Exclusion criteria

* Use of systemic medications (e.g., corticosteroids, immunosuppressants) or treatments affecting hair regrowth within the last 3 months. * History of hypersensitivity or adverse reactions to laser therapy * Active systemic diseases such as uncontrolled diabetes, autoimmune disorders, or malignancies * Pregnant or breastfeeding individuals. * Patients with pacemakers or implanted medical devices contraindicated with low level laser therapy. * History of hair transplant surgery in the treatment area

Design outcomes

Primary

MeasureTime frameDescription
Physician's Global Assessment (PGA) scale12 MonthsThe Physician's Global Assessment (PGA) scale is a tool used by physicians to evaluate the overall severity of a patient's disease. It's a subjective assessment, typically on a scale of 0 to 3 or 0 to 4, with higher scores indicating more severe disease activity. The PGA focuses on the overall disease activity, considering both the severity of active manifestations and relevant laboratory results, excluding organ damage and subjective findings unrelated to disease activity

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026